Economic impact of enhanced recovery after surgery protocol in minimally invasive cardiac surgery.
Cost analysiss
ERAS
Enhanced recovery after surgery
Minimally invasive cardiac surgery
Perioperative care
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
20 Mar 2021
20 Mar 2021
Historique:
received:
20
10
2020
accepted:
26
02
2021
entrez:
21
3
2021
pubmed:
22
3
2021
medline:
15
5
2021
Statut:
epublish
Résumé
ERAS (Enhanced Recovery After Surgery) is a multidisciplinary and integrative approach with the goal of optimizing the postoperative recovery. We aimed to analyze the economic impact of a newly established ERAS protocol in minimally invasive heart valve surgery at our institution. ERAS protocol was implemented in 61 consecutive patients who were referred for elective minimally-invasive aortic or mitral valve surgery, between February 1, 2018 and March 31, 2019 (ERAS-group). Another 69 patients who underwent elective minimally-invasive heart valve surgery during the same time period were managed according to the hospital standards (Control-group). A detailed cost comparison analysis was carried out from a hospital perspective using a micro-costing approach. The total in-hospital stay was significantly shorter in the ERAS-group compared to the Control-group (6.1 ± 2.6 vs 7.7 ± 3.8 days; p = 0.008) resulting in significant cost savings of €1087.2 per patient (p = 0.003). Due to the intensified physiotherapy in the ERAS protocol, the costs for physiotherapy were €94.3 higher compared to the Control-group (p < 0.001). The total costs in the ERAS cohort were €11,200.0 ± 3029.6/patient compared to € 13,109.8 ± 4527.5/patient in the Control-Group resulting in cost savings of €1909.8 patient due to the implementation of the ERAS protocol (p = 0.006). Implementation of an ERAS-protocol in minimally-invasive cardiac surgery can be carried out safely with a fast postoperative recovery of the patient. ERAS results in a financial benefit of up to €1909 per patient and therefore will play a key role in modern cardiac surgery in the near future.
Sections du résumé
BACKGROUND
BACKGROUND
ERAS (Enhanced Recovery After Surgery) is a multidisciplinary and integrative approach with the goal of optimizing the postoperative recovery. We aimed to analyze the economic impact of a newly established ERAS protocol in minimally invasive heart valve surgery at our institution.
METHODS
METHODS
ERAS protocol was implemented in 61 consecutive patients who were referred for elective minimally-invasive aortic or mitral valve surgery, between February 1, 2018 and March 31, 2019 (ERAS-group). Another 69 patients who underwent elective minimally-invasive heart valve surgery during the same time period were managed according to the hospital standards (Control-group). A detailed cost comparison analysis was carried out from a hospital perspective using a micro-costing approach.
RESULTS
RESULTS
The total in-hospital stay was significantly shorter in the ERAS-group compared to the Control-group (6.1 ± 2.6 vs 7.7 ± 3.8 days; p = 0.008) resulting in significant cost savings of €1087.2 per patient (p = 0.003). Due to the intensified physiotherapy in the ERAS protocol, the costs for physiotherapy were €94.3 higher compared to the Control-group (p < 0.001). The total costs in the ERAS cohort were €11,200.0 ± 3029.6/patient compared to € 13,109.8 ± 4527.5/patient in the Control-Group resulting in cost savings of €1909.8 patient due to the implementation of the ERAS protocol (p = 0.006).
CONCLUSION
CONCLUSIONS
Implementation of an ERAS-protocol in minimally-invasive cardiac surgery can be carried out safely with a fast postoperative recovery of the patient. ERAS results in a financial benefit of up to €1909 per patient and therefore will play a key role in modern cardiac surgery in the near future.
Identifiants
pubmed: 33743698
doi: 10.1186/s12913-021-06218-5
pii: 10.1186/s12913-021-06218-5
pmc: PMC7981978
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
254Références
Anesthesiology. 2008 Jul;109(1):61-6
pubmed: 18580173
Anesthesiology. 1998 Jun;88(6):1429-33
pubmed: 9637632
Am J Respir Crit Care Med. 2002 Jul 1;166(1):111-7
pubmed: 12091180
Ann R Coll Surg Engl. 2015 Apr;97(3):173-9
pubmed: 26263799
Ann Thorac Surg. 1997 Jul;64(1):134-41
pubmed: 9236349
Eur J Cardiothorac Surg. 2018 Sep 1;54(3):491-497
pubmed: 29514224
Cochrane Database Syst Rev. 2016 Sep 12;9:CD003587
pubmed: 27616189
Eur J Cardiothorac Surg. 2018 May 1;53(suppl_2):ii14-ii18
pubmed: 29370357
Surg Today. 2015 Sep;45(9):1144-52
pubmed: 26112649
Gynecol Oncol. 2016 Feb;140(2):313-22
pubmed: 26603969
Ann Thorac Surg. 1994 Dec;58(6):1742-6
pubmed: 7979747
World J Surg. 2016 Sep;40(9):2065-83
pubmed: 26943657
Acta Anaesthesiol Scand. 2016 Mar;60(3):289-334
pubmed: 26514824
Acta Obstet Gynecol Scand. 2011 Apr;90(4):362-8
pubmed: 21306322
Langenbecks Arch Chir Suppl Kongressbd. 1996;113:303-6
pubmed: 9101859
J Gastrointest Surg. 2009 Dec;13(12):2321-9
pubmed: 19459015
BMJ. 2001 Feb 24;322(7284):473-6
pubmed: 11222424
J Visc Surg. 2011 Jun;148(3):e157-9
pubmed: 21733773
Clin Nutr. 2013 Dec;32(6):879-87
pubmed: 24189391
J Thorac Cardiovasc Surg. 2019 May;157(5):1881-1888
pubmed: 30665758
JAMA Surg. 2019 Aug 1;154(8):755-766
pubmed: 31054241
World J Surg. 2013 Feb;37(2):240-58
pubmed: 22956014
Dtsch Arztebl Int. 2019 Feb 1;116(5):73-82
pubmed: 30950393